1 Min Read
March 19 (Reuters) - Edwards Lifesciences Corp:
* EDWARDS LIFESCIENCES CORP - U.S. FDA GRANTED DE NOVO REQUEST FOR EDWARDS’ ACUMEN HYPOTENSION PREDICTION INDEX SOFTWARE Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.